Legacy Wealth Planning’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$580K Sell
12,290
-700
-5% -$36.3K 0.96% 27
2022
Q2
$655K Hold
12,990
0.94% 28
2022
Q1
$792K Buy
12,990
+1,806
+16% +$108K 0.93% 27
2021
Q4
$736K Sell
11,184
-300
-3% -$19.2K 0.84% 29
2021
Q3
$721K Hold
11,484
0.81% 31
2021
Q2
$691K Buy
11,484
+150
+1% +$8.68K 0.79% 31
2021
Q1
$624K Buy
11,334
+966
+9% +$53.6K 0.8% 31
2020
Q4
$566K Hold
10,368
0.73% 30
2020
Q3
$518K Sell
10,368
-174
-2% -$8.43K 0.59% 34
2020
Q2
$465K Buy
10,542
+726
+7% +$31K 0.55% 34
2020
Q1
$369K Sell
9,816
-318
-3% -$13.4K 0.59% 35
2019
Q4
$446K Buy
+10,134
New +$426K 0.51% 38

Other funds holding IHI

Legacy Wealth Planning's IHI Position: Q3 2022 in Review

Legacy Wealth Planning reduced its iShares US Medical Devices ETF (IHI) stake by 5.4% in Q3 2022, selling an estimated $36.3K and leaving 12,290 shares worth $580K. The position accounts for 0.96% of the portfolio, ranked #27.

Legacy Wealth Planning first reported a position in IHI in Q4 2019 and has held it in 12 quarters since. The position peaked at $792K in Q1 2022. 556 funds tracked by Wall St. Rank hold IHI as of Q3 2022.

  • Legacy Wealth Planning held 12,290 shares of iShares US Medical Devices ETF worth $580K as of Q3 2022.
  • Legacy Wealth Planning sold 700 iShares US Medical Devices ETF shares in Q3 2022, an estimated $36.3K.
  • iShares US Medical Devices ETF made up 0.96% of Legacy Wealth Planning's portfolio in Q3 2022, its #27 holding.
  • Legacy Wealth Planning first reported a position in iShares US Medical Devices ETF in Q4 2019 and has held it in 12 quarters since.
  • Legacy Wealth Planning's iShares US Medical Devices ETF position peaked at $792K in Q1 2022.
  • 556 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q3 2022.

Based on Legacy Wealth Planning's 13F filing for Q3 2022, filed 10 Nov 2022.